Maxwell Skor
Stock Analyst at Morgan Stanley
(0.59)
# 3,934
Out of 4,905 analysts
5
Total ratings
40%
Success rate
-10.88%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Maxwell Skor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASND Ascendis Pharma | Assumes: Overweight | $250 | $169.90 | +47.15% | 1 | Jul 3, 2025 | |
| SANA Sana Biotechnology | Assumes: Overweight | $12 | $4.63 | +159.18% | 1 | Jul 3, 2025 | |
| TCRX TScan Therapeutics | Assumes: Overweight | $10 | $1.82 | +449.45% | 1 | Mar 14, 2025 | |
| IVVD Invivyd | Maintains: Overweight | $9.5 → $3.55 | $0.75 | +374.92% | 2 | Nov 20, 2024 |
Ascendis Pharma
Jul 3, 2025
Assumes: Overweight
Price Target: $250
Current: $169.90
Upside: +47.15%
Sana Biotechnology
Jul 3, 2025
Assumes: Overweight
Price Target: $12
Current: $4.63
Upside: +159.18%
TScan Therapeutics
Mar 14, 2025
Assumes: Overweight
Price Target: $10
Current: $1.82
Upside: +449.45%
Invivyd
Nov 20, 2024
Maintains: Overweight
Price Target: $9.5 → $3.55
Current: $0.75
Upside: +374.92%